Rubedo Life Sciences reposted this
Standing room only on Day 1 #BIO2024 #longevity #medicine panel as Rubedo Life Sciences CEO Marco Quarta and BoD member Robert Gould take the stage alongside other leaders in the field 🔥🔥🔥
Rubedo Life Sciences
Biotechnology
Sunnyvale, California 6,022 followers
Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging
About us
Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. Our proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders. The Rubedo leadership team is composed of industry leaders and pioneers in chemistry, technology, and the life sciences, with a deep bench of expertise in drug development and commercialization spanning from large pharma to biotech innovators. The company is based in Sunnyvale, CA.
- Website
-
https://www.rubedolife.com
External link for Rubedo Life Sciences
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Sunnyvale, California
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
Get directions
Sunnyvale, California 94085, US
Employees at Rubedo Life Sciences
Updates
-
Rubedo Life Sciences reposted this
Excited to speak at BIO International Convention 2024 panel today on #longevity #therapeutics with leaders from Novartis , Rubedo Life Sciences, Mubadala , Juvena Therapeutics, & Khosla Ventures moderated by The Wall Street Journal. If you are at BIO, I hope to see you there! 👉🏾 Today @3-4pm Rm 23BC
-
-
Rubedo Life Sciences reposted this
Don't miss this headlining #BIO2024 panel today on #longevity #therapeutics with leaders from Novartis, Rubedo Life Sciences, Mubadala Capital, Juvena Therapeutics, & Khosla Ventures moderated by The Wall Street Journal 👉🏾 Today @3-4pm Rm 23BC
-
-
Rubedo Life Sciences reposted this
From a five-year-old scientist to a leader cutting edge longevity medicines, LEAP 2024 speaker Marco Quarta (Co-Founder and CEO at Rubedo Life Sciences) has dedicated his life to treating age-related disease. Read the blog now on why we should turn back the clock on ageing 👀 - https://bit.ly/3KdQINj #LEAP25 #healthtech #lifesciences
-
Rubedo Life Sciences reposted this
Rubedo Life Sciences is rejoining the US-UAE Business Council in Philly this Thursday for the #AbuDhabi #LifeSciences Reception ahead of #BIO2024. Calling all US #healthcare ecosystem, it's a great opportunity to meet senior leadership from the #UAE. Register your interest here bit.ly/4bD7qSs #biotech #biopharma #digitalhealth #medtech #diagnostics #healthtech
-
-
Our CEO dr. Marco Quarta will be speaking along with other leaders in the Biotech, Pharma and Ventures at BIO International Convention on the panel https://lnkd.in/gMKxRzHZ. We hope to see you there.
I am thrilled to announce that I will be speaking at BIO International Convention 2024, representing Rubedo Life Sciences. This year, I am honored to share the stage with a remarkable group of panelists including Hanadie Yousef founder and CEO at Juvena Therapeutics, Robert Gould at operating partner Khosla Ventures, Cristina Ghenoiu, Ph.D. partner at Mubadala, Simone Fantaccini, MD, MBA CSO and Head of Medical Affairs at Novartis, and moderator Brian Gormley Special Writer at The Wall Street Journal. At Rubedo, we are dedicated to developing the next generation of selective medicine targeting cellular senescence, underlying driver of chronic diseases. We are on the verge of entering the clinic soon with our first program focusing on chronic inflammatory skin conditions, paving the way for expansion into other tissues and organs across various therapeutic areas. It is truly exciting to witness companies such as Rubedo and Juvena pioneering in the field of Longevity Therapeutics, moving from specific indications to broader and multiple therapeutic areas. Special Kudos to Ali Siam, Rubedo CBO, who is the brilliant mind behind this, promoter and organizer of this amazing Panel. Thank you. For more information about the panel and details, you can visit the link below: https://lnkd.in/gwn-iY4q
-
-
Rubedo Life Sciences reposted this
It is great to present at the SID annual meeting some of the latest research from Rubedo Life Sciences
-
-
Rubedo Life Sciences reposted this
Incredible two days representing Rubedo Life Sciences in #AbuDhabi during #ADGHW! Grateful to the leadership at M42 Health, Abu Dhabi Investment Office, Department of Health Abu Dhabi, Cleveland Clinic Abu Dhabi, Technology Innovation Institute, Masdar City, PureHealth, Emirates Drug Establishment, & the U.S. Mission to the UAE for their hospitality
-
-
-
-
-
+3
-
-
Rubedo Life Sciences reposted this
Honored to represent Rubedo Life Sciences this week on the US-UAE Business Council #lifesciences trade mission during the inaugural Abu Dhabi Global Healthcare Week championed by the Department of Health Abu Dhabi. #MENA + #GCC growing leadership in #longevity #medicine 💪🏾 ⚕ 💊 #ADGHW #AbuDhabi #TransformingHealthcare #Healthcare #Biotech
-
-
Rubedo Life Sciences reposted this
Had an amazing time presenting the progress of Rubedo Life Sciences at #RejuvenationStartupSummit2024 in Berlin and connecting with colleagues and friends- old and new. Longevity Medicine is a rapidly growing field with many exciting therapeutic opportunities and companies advancing towards the clinic, that will revolutionize the future of medicine. Kudos to the event organizers for putting together such a fantastic event. A special thanks to Frank Schueler and Michael Greve for their invitation and for the great work they are doing to support this echosistem! #LongevityMedicine #FutureOfMedicine
-